Percutaneous balloon valvuloplasty of pulmonary valve stenosis: state of the art and future prospects


  • Md Faisal Talukder Department of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China
  • Li Hongxin Department of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China
  • Liang Fei Department of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China
  • Muhsin Billah Bin Khashru Department of Hand and Foot Surgery, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong, China



Balloon pulmonary valvuloplasty, Congenital heart disease, Pulmonary insufficiency, Pulmonary stenosis


This study is aimed to delineate readers with an overview of percutaneous balloon pulmonary valvuloplasty (PBPV) of pulmonary valve stenosis (PVS) and highlighting outcome based on influential and recent studies. It has been four decades since Kan et al first introduce PBPV. Since then, PBPV has recognized as a gold standard therapy for PVS of all ages. Nowadays, PBPV is practiced for a broad range of indication such as PVS, PV dysplasia and pulmonary atresia. Typically, PBPV is recommended when gradient across the PV is >50 mmHg. The procedure involves the placement of one or more balloon catheters across the stenotic PV with the guidance of a guidewire; thereafter, inflation of the balloons is done by pressure, thus producing valvotomy. Nowadays, PBPV is done by echocardiographic guidance, but previously, it was done by fluoroscopic guidance. The main disadvantage of fluoroscopy was the radiation injury of patients. The recently recommended balloon/annulus ratio is 1.2 to 1.25. Following the procedure, the dramatic reduction of pressure gradient, free motion of the PV leaflets with less doming, the rise of cardiac output have been noted, whereas complications may occur but are unusual and minimal. Significant predictors of restenosis include balloon/annulus ratio <1.2 and immediate post-PBPV gradient ≥30 mmHg. Only a few percentages of patients needed repeat PBPV. Long-term follow-up results are surprisingly excellent. In conclusion, it is our opinion that PBPV is equally successful in patients of all ages, while worldwide recognized studies prove the safety, feasibility, and effectiveness. However, for early detection of any complication, life-long clinical follow-up is mandatory.

Author Biography

Md Faisal Talukder, Department of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China

Resident Cardiac Surgeon


van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, Roos-Hesselink JW. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am College Cardiol. 2011;58(21):2241-7.

Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Inter J Epidemiol. 2019;48(2):455-63.

Capucci A, Aschieri D. Public access defibrillation: new developments for mass implementation. Heart. 2011;97(18):1528-32.

Rao PS. Percutaneous balloon pulmonary valvuloplasty: state of the art. Catheter Cardio Intervent. 2007;69(5):747-63.

Benson LN, Smallhorn JS, Freedom RM, Trusler GA, Rowe RD. Pulmonary valve morphology after balloon dilatation of pulmonary valve stenosis. Catheter Cardio Diagnos. 1985;11(2):161-6.

Sellors TH. Surgery of pulmonary stenosis: a case in which the pulmonary valve was successfully divided. The Lancet. 1948;251(6513):988-9.

Swan H, Zeavin I, Blount SG, Virtue RW. Surgery by direct vision in the open-heart during hypothermia. J Am Med Associat. 1953;153(12):1081-5.

Rubio V, Limon-Lason R. Treatment of pulmonary valvular stenosis and tricuspid stenosis using a modified catheter. In Second World Congress on Cardiol. 1954;2:205-10.

Semb BK, Tjönneland S, Stake G, Aabyholm G. “Balloon valvulotomy” of congenital pulmonary valve stenosis with tricuspid valve insufficiency. Cardio Radiol. 1979;2(4):239-41.

Kan JS, White RI, Mitchell SE, Gardner TJ. Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary-valve stenosis. New Eng J Med. 1982;307(9):540-2.

Gruntzig AR, Senning A, Siegothaler WE. Non-operative dilatation of coronary artery stenosis: Percutaneous transluminal coronary angioplasty. New Eng J Med. 1979;301:61-8.

Wang SZ, Ou‐yang WB, Hu SS, Pang KJ, Liu Y, Zhang FW, et al. First‐in‐human percutaneous balloon pulmonary valvuloplasty under echocardiographic guidance only. Congenital Heart Dis. 2016;11(6):716-20.

Nugent EW, Freedom RM, Nora JJ, Ellison RC, Rowe RD, Nadas AS. Clinical course in pulmonary stenosis. Circulation. 1977;56: I38-47.

Rao PS. Balloon dilatation in infants and children with dysplastic pulmonary valves: short-term and intermediate-term results. Am Heart J. 1988;116(5):1168-73.

Rao PS. Pulmonary valve disease. In: Alpert JS, Dalen JE, Rahimtoola S, editors. Valvular Heart Disease, 3rd ed. Philadelphia, PA: Lippincott Raven; 2000:339-376.

Fedderly RT, Lloyd TR, Mendelsohn AM, Beekman RH. Determinants of successful balloon valvotomy in infants with critical pulmonary stenosis or membranous pulmonary atresia with intact ventricular septum. J Am College Cardiol. 1995;25(2):460-5.

Qian X, Qian Y, Zhou Y, Yang X. Percutaneous pulmonary balloon valvuloplasty provides good long-term outcomes in adults with pulmonary valve stenosis. J Invasive Cardiol. 2015;27(12):E291-6.

Chaara A, Zniber L, Benomar M. Percutaneous balloon valvuloplasty via the right internal jugular vein for valvular pulmonic stenosis with severe right ventricular failure. Am Heart J. 1989;117(3):684-5.

Sideris EB, Baay JE, Bradshaw RL, Jones JE. Axillary vein approach for pulmonic valvuloplasty in infants with iliac vein obstruction. Catheter Cardio Diag. 1988;15(1):61-3.

Shim D, Lloyd TR, Cho KJ, Moorehead CP, Beekman RH. Transhepatic cardiac catheterization in children: evaluation of efficacy and safety. Circ. 1995;92(6):1526-30.

Kim, Gi-Beom, Bae EJ, Noh C. Balloon valvuloplasty for neonatal critical pulmonary valvar stenosis with IVC interruption: pitfalls of the transumbilical approach. J Korean Med Sci. 2010;25(3):485-8.

Rao PS. Further observations on the effect of balloon size on the short-term and intermediate-term results of balloon dilatation of the pulmonary valve. Br Heart J. 1988;60:507-11.

Ring JC, Kulik TJ, Burke BA, Lock JE. Morphologic changes induced by dilation of the pulmonary valve anulus with overlarge balloons in normal newborn lambs. The Am J Cardio. 1985;55(1):210-4.

Garty Y, Veldtman G, Lee K, Benson L. Late outcomes after pulmonary valve balloon dilatation in neonates, infants and children. J Invasive Cardiol. 2005;17:318-22.

Rao PS. Late pulmonary insufficiency after balloon dilatation of the pulmonary valve (Letter). Catheter Cardiovasc Interv. 2000;49:118-9.

Loureiro P, Cardoso B, Gomes IB, Martins JF, Pinto FF. Long-term results of percutaneous balloon valvuloplasty in neonatal critical pulmonary valve stenosis: a 20-year, single center experience. Cardiol Young. 2017;27(7):1314-22.

Attia I, Weinhaus L, Walls JT, Lababidi Z. Rupture of tricuspid papillary muscle during balloon pulmonary valvuloplasty. Am Heart J. 1987;114:1233-4.

Lo RNS, Lau KC, Leung MP. Complete heart block after balloon dilatation of congenital pulmonary stenosis. Br Heart J. 1988;59:384-6.

Narang R, Das G, Dev V, Goswami K, Saxena A, Shrivastava S. Effect of the balloon-anulus ratio on the intermediate and follow-up results of pulmonary balloon valvuloplasty. Cardiol. 1997;88(3):271-6.

Rao PS, Fawzy ME. Double balloon technique for percutaneous balloon pulmonary valvuloplasty: Comparison with single balloon technique. J Interv Cardiol. 1988;1:257-62.

Escalera RB, Chase TJ, Owada CY. Triple-balloon pulmonary valvuloplasty: an advantageous technique for percutaneous repair of pulmonary valve stenosis in the large pediatric and adult patient. Catheter Cardiovasc Interv. 2006;66:446-51.

Meier B, Friedli B, Oberhaensli I, Belenger J, Finci L. Trefoil balloon for percutaneous valvuloplasty. Catheter Cardio Diagnos. 1986;12(4):277-81.

Meier B, Friedli B. Valvuloplasty with trefoil and bifoil balloons and the long sheath technique. Herz. 1988;13(1):1-3.

Lau KW, Hung JS, Wu JJ, Chern MS, Yeh KH, Fu M. Pulmonary valvuloplasty in adults using the Inoue balloon catheter. Catheter Cardio Diag. 1993;29(2):99-104.

Kilic T, Sahin T, Karauzum K, Ural E, Pedersen WR. New pulmonary valvuloplasty technique by use of an hourglass-shaped balloon in 3 adults with severe pulmonary valve stenosis. Texas Heart Institute J. 2018;45(2):76-83.

Stanger P, Cassidy SC, Girod DA, Kan JS, Lababidi Z, Shapiro SR. Balloon pulmonary valvuloplasty: results of the valvuloplasty and angioplasty of congenital anomalies registry. The Am J Cardiol. 1990;65(11):775-83.

Ostovan MA, Kamali M, Zolghadrasli A. A case of fatal acute lung injury after balloon valvuloplasty of pulmonary stenosis: case report and review of literature. J Cardio Thoracic Res. 2015;7(2):78.

Rao PS. Pulmonary valve in children. Sigwart U, Bertrand M, Serruys PW. Handbook of Cardiovascular Interventions, Churchill Livingstone, New York; 1996: 273-310.

Rao PS, Galal O, Wilson AD. Feasibility and effectiveness of repeat balloon dilatation of restenosed obstructions following previous balloon valvuloplasty/ angioplasty. Am Heart J. 1996;132:403-7.

Nishimura RA, Holmes DR, Reeder GS. Percutaneous balloon valvuloplasty. In Mayo Clinic Proceedings. 1990;65(2):198-220.

Walls JT, Lababidi Z, Curtis JJ, Silver D. Assessment of percutaneous balloon pulmonary and aortic valvuloplasty. J Thoracic Cardio Surg. 1984;88(3):352-6.

McCrindle BW, Independent predictors of long-term results after balloon pulmonary valvuloplasty. Valvuloplasty Angioplasty Congenital Anomalies (VACA) Reg Invest Circulat. 1994;89:1751-9.

Berman W, Fripp RR, Raisher BD, Yabek SM. Significant pulmonary valve incompetence following oversize balloon pulmonary valvoplasty in small infants: a long-term follow-up study. Catheter Cardiovasc Interv. 1999;48:61-5.

Peterson C, Schilthuis JJ, Dodge-Khatami A, Hitchcock JF, Meijboom EJ, Bennink GB. Comparative long-term results of surgery versus balloon valvuloplasty for pulmonary valve stenosis in infants and children. Ann Thorac Surg. 2003;76:1078-82.

Karagoz T, Asoh K, Hickey E, Chaturvedi R, Lee KJ, Nykanen D, et al. Balloon dilation of pulmonary valve stenosis in infants less than 3 kg: A 20‐year experience. Catheter Cardio Interv. 2009;74(5):753-61.

Bhati BS, Nandakumaran CP, Shatapathy P, John S, Cherian G. Closure of patent ductus arteriosus during open-heart surgery. Surgical experience with different techniques. J Thorac Cardiovasc Surg. 1972;63:820-6.

Hjortdal VE, Redington AN, De Leval MR, Tsang VT. Hybrid approaches to complex congenital cardiac surgery. Eur J Cardio-thoracic Surg. 2002;22(6):885-90.

Bouzas-Mosquera A, Rueda F, Aldama G, Medrano C, Portela F, Zavanella C, Castro-Beiras A. Perventricular pulmonary valvuloplasty under echocardiographic guidance. International journal of cardiology. 2008;130(3):e102-4.

Lin ZQ, Chen Q, Cao H, Chen LW, Zhang GC, Chen DZ, et al. Transthoracic balloon pulmonary valvuloplasty for treatment of congenial pulmonary atresia patients with intact ventricular septum. Medical science monitor. Inter Med J Experiment Clin Res. 2017;23:4874.

Tulzer G, Arzt W, Franklin RC, Loughna PV, Mair R, Gardiner HM. Fetal pulmonary valvuloplasty for critical pulmonary stenosis or atresia with intact septum. The Lancet. 2002;360(9345):1567-8.






Review Articles